Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Bridgewater Associates11,775주2026-06-30 · 증감 -18587주
AbbVie's company information is shown as of 2026-10-02. It is a security listed on New York Stock Exchange, ticker ABBV. There are 10 published related companies.
AbbVie last closed at $262.82 (+1.11%) on 2026-10-02. Signals today: Near 52-week high, MA aligned, VCP. Listed on New York Stock Exchange.
A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
A curated subset of well-known investors — not the full institutional ownership.
US name matches 1521/1802 · KR cache checked 3649/3649 stocks
Factual filing information, not investment advice.
면역·종양·염증 치료제에서 경쟁
대형 제약사로 항암·면역질환 분야 경쟁
종양학 중심 핵심 경쟁사
면역·비만·대사질환 등 대형 파이프라인 경쟁
면역학·바이오의약품 영역 경쟁
항암제 및 면역질환 치료제 경쟁
AbbVie의 주요 성장품목이자 면역질환 테마
AbbVie의 핵심 면역질환 성장품목
AbbVie의 역사적 핵심 매출품목이자 바이오시밀러 경쟁의 중심
AbbVie 분사 모회사로 역사적 연관성이 큰 기업
2026-10-03 dataset
Passive money holding this stock ≈ $17.4B(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →